Vertex Pharmaceuticals Inc (VRTX)
392.98
-3.22
(-0.81%)
USD |
NASDAQ |
Apr 30, 16:00
392.10
-0.88
(-0.22%)
After-Hours: 17:48
Vertex Pharmaceuticals Free Cash Flow: 3.279B for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.279B |
| September 30, 2023 | 4.205B |
| June 30, 2023 | 3.879B |
| March 31, 2023 | 3.890B |
| December 31, 2022 | 3.925B |
| September 30, 2022 | 3.814B |
| June 30, 2022 | 3.787B |
| March 31, 2022 | 2.451B |
| December 31, 2021 | 2.408B |
| September 30, 2021 | 1.919B |
| June 30, 2021 | 1.777B |
| March 31, 2021 | 3.048B |
| December 31, 2020 | 2.994B |
| September 30, 2020 | 2.979B |
| June 30, 2020 | 2.557B |
| March 31, 2020 | 1.983B |
| December 31, 2019 | 1.494B |
| September 30, 2019 | 1.364B |
| June 30, 2019 | 1.414B |
| March 31, 2019 | 1.258B |
| December 31, 2018 | 1.175B |
| September 30, 2018 | 1.060B |
| June 30, 2018 | 682.12M |
| March 31, 2018 | 554.31M |
| December 31, 2017 | 585.52M |
| Date | Value |
|---|---|
| September 30, 2017 | 530.93M |
| June 30, 2017 | 600.58M |
| March 31, 2017 | 461.24M |
| December 31, 2016 | 179.54M |
| September 30, 2016 | 66.22M |
| June 30, 2016 | -56.42M |
| March 31, 2016 | -205.05M |
| December 31, 2015 | -410.73M |
| September 30, 2015 | -623.81M |
| June 30, 2015 | -649.88M |
| March 31, 2015 | -665.82M |
| December 31, 2014 | -624.31M |
| September 30, 2014 | -422.57M |
| June 30, 2014 | -357.86M |
| March 31, 2014 | -220.96M |
| December 31, 2013 | -112.06M |
| September 30, 2013 | -104.83M |
| June 30, 2013 | 11.96M |
| March 31, 2013 | 117.56M |
| December 31, 2012 | 196.70M |
| September 30, 2012 | 738.52M |
| June 30, 2012 | 686.87M |
| March 31, 2012 | 297.38M |
| December 31, 2011 | 109.14M |
| September 30, 2011 | -625.72M |
Free Cash Flow Range, Past 5 Years
1.364B
Minimum
Sep 2019
4.205B
Maximum
Sep 2023
2.798B
Average
2.979B
Median
Sep 2020
Free Cash Flow Benchmarks
| Amgen Inc | 7.359B |
| Eli Lilly and Co | -3.152B |
| Regeneron Pharmaceuticals Inc | 3.668B |
| Alpine Immune Sciences Inc | -79.50M |
| Moderna Inc | -3.825B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 234.60M |
| Cash from Investing (Quarterly) | -886.50M |
| Cash from Financing (Quarterly) | -119.80M |
| Free Cash Flow Per Share (Quarterly) | 0.4544 |
| Free Cash Flow to Equity (Quarterly) | 118.50M |
| Free Cash Flow to Firm (Quarterly) | 118.50M |
| Free Cash Flow Yield | 3.20% |